Pseudo-precocious puberty caused by a juvenile granulosa cell tumour secreting androstenedione, inhibin and insulin-like growth factor-I

Journal of Pediatric Endocrinology and Metabolism

Volumn 17, Issue 4, 2004, Pages 679-684

  Chan, L F ^a   Storr, H L ^a   Scheimberg, I ^a   Perry, L A ^a   Banerjee, K ^a   Miraki Moud, F ^a   Camacho Hubner C ^a   Savage, Martin O ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Androgens; Inhibin; Juvenile granulosa cell tumour; Pseudo precocious puberty

Indexed keywords

ANDROSTENEDIONE; ESTRADIOL; FOLLITROPIN; FUSIDATE SODIUM; INHIBIN; KETOCONAZOLE; LUTEINIZING HORMONE; MELAN A; MONOCLONAL ANTIBODY; PRASTERONE SULFATE; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN C;

ABDOMINAL PAIN; ABDOMINAL RADIOGRAPHY; ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; BIOCHEMISTRY; BONE AGE; CASE REPORT; CONVALESCENCE; DERMATITIS; DISEASE ASSOCIATION; ECZEMA; ESTRADIOL BLOOD LEVEL; FEMALE; GRANULOSA CELL TUMOR; HISTOPATHOLOGY; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HORMONE RELEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LAPAROTOMY; OVARY TUMOR; PRECOCIOUS PUBERTY; PRESCHOOL CHILD; SALPINGOOOPHORECTOMY; VAGINA BLEEDING;

EID: 3142772964     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2004.17.4.679     Document Type: Article

References (25)

1. Scully RE. Sex cord-stromal tumours. In: Blaustein A, ed. Pathology of the Female Genital Tract. New York: Springer-Verlag, 1977; 505-526.
2. Bouffet E, Basset T, Chetail N, Dijoud F, Mollard P, Brunat-Mentigny M, David M. Juvenile granulosa cell tumour of the ovary in infants: a clinicopathologic study of three cases and review of the literature. J Pediatr Surg 1997; 32: 762-765.
3. Lappohn RE, Burger HG, Bouma J, Bangah M, Krans M, de Bruijn HW. Inhibin as a marker for granulosa cell tumours. N Engl J Med 1989; 321: 790-793.
4. Burger HG, Fuller PJ, Chu S, Mamers P, Drummond A, Susil B, Neva P, Robertson DM. The inhibins and ovarian cancer. Mol Cell Endocrinol 2001; 180: 145-148.
5. Silverman LA, Gitelman SE. Immunoreactive inhibin, Müllerian inhibitory substance, and activin as biochemical markers for juvenile granulosa cell tumours. J Pediatr 1996; 129: 918-921.
6. Nishida M, Jimi S, Haji M, Hayashi I, Kai T, Tasaka H. Juvenile granulosa cell tumour in association with high serum inhibin level. Gynecol Oncol 1991; 40: 90-94.
7. Loo KT, Leung AK, Chan JK. Immunohistochemical staining of ovarian granulosa cell tumours with MIC-2 antibody. Histopathology 1995; 27: 388-390.
8. Stewart CJ, Nandini CL, Richmond JA. Value of A103 (melan-A) immunostaining in the differential diagnosis of ovarian sex cord stromal tumours. J Clin Pathol 2000; 53: 206-211.
9. Morrell DJ, Dadi H, More J, Taylor AM, Dabestani A, Buchanan CR, Holder AT, Preece MA. A monoclonal antibody to human insulin-like growth factor-I: characterisation, use in radioimmunoassay and effect on the biological activities of the growth factor. J Mol Endocrinol 1989; 2: 201-206.
10. Hsu SM, Raine L, Fanger H. Use of the avidin-biotin peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981; 29: 577-580.
11. Young RH, Dickersin GR, Scully RE. Juvenile granulosa cell tumour of the ovary: a clinicopathological analysis of 125 cases. Am J Surg Pathol 1984; 8: 575-594.
12. Fox H. Sex cord-stromal tumours of the ovary. J Pathol 1985; 145: 127-148.
13. Pysher TJ, Hitch DC, Krous HF. Bilateral juvenile granulosa cell tumours in a 4-month-old dysmorphic infant: a clinical, histologic, and ultrastructural study. Am J Surg Pathol 1981; 5: 789-794.
14. Tamini HK, Bolen JW. Enchondromatosis (Ollier's disease) and ovarian juvenile granulosa cell tumor. Cancer 1984; 53: 1605-1608.
15. Lewis RJ, Ketcham AS. Maffucci's syndrome: functional and neoplastic significance. Case report and review of the literature. J Bone Joint Surg 1973; 55: 1465-1479.
16. Young RH, Lawrence WD, Scully RE. Juvenile granulosa cell tumour - another neoplasm associated with abnormal chromosomes and ambiguous genitalia. A report of three cases. Am J Surg Pathol 1985; 9: 737-743.
17. Piltonen T, Koivunen R, Morin-Papunen L, Ruokonen A, Huhtaniemi IT, Tapanainen JS. Ovarian and adrenal steroid production: regulatory role of LH/HCG. Hum Reprod 2002; 17: 620-624.
18. Crofton PM, Evans AE, Groome NP, Taylor MR, Holland CV, Kelnar CJ. Dimeric inhibins in girls from birth to adulthood: relationship with age, pubertal stage, FSH and oestradiol. Clin Endocrinol 2002; 56: 223-230.
19. Hee JP, MacNaughton J, Bangah M, Zissimos M, McCloud PI, Healy DL, Burger HG. Follicle-stimulating hormone induces dose-dependant stimulation of immunoreactive inhibin secretion during the follicular phase of the human menstrual cycle. J Clin Endocrinol Metab 1993; 76: 1340-1343.
20. Petraglia F, Zanin E, Faletti A, Reis FM. Inhibins: paracrine and endocrine effects in female reproductive function. Curr Opin Obstet Gynecol 1999; 11: 241-247.
21. Pigny P, Desailloud R, Cortet-Rudelli C, Duhamel A, Deroubaix-Allard D, Racadot A, Dewailly D. Serum alpha-inhibin levels in polycystic ovary syndrome: relationship to serum androstenedione level. J Clin Endocrinol Metab 1997; 82: 1939-1943.
22. Matzuk MM, Finegold MJ, Su JG, Hsueh AJ, Bradley A. Alpha-inhibin is a tumour-suppressor gene with gonadal specificity in mice. Nature 1992; 360: 313-319.
23. McMullen ML, Cho BN, Yates CJ, Mayo KE. Gonadal pathologies in transgenic mice expressing the rat inhibin alpha-subunit. Endocrinology 2001; 142: 5005-5014.
24. Poretsky L, Cataldo NA, Rosenwaks Z, Guidice LC. The insulin-related ovarian regulatory system in health and disease. Endocr Rev 1999; 20: 535-582.
25. Burke F, Relf M, Negus R, Balkwill F. A cytokine profile of normal and malignant ovary. Cytokine 1996; 8: 578-585.